VO659 clinical trials

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

This study is testing a new drug called VO659 for people with certain genetic conditions affecting movement: Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, and Huntington's Disease. It's looking at how safe the drug is and how the body handles it. This is a very early stage trial.